Megakaryocytes, malignancy and bone marrow vascular niches.
Psaila B. et al, (2012), J Thromb Haemost, 10, 177 - 188
The Effect of Eltrombopag on Platelet Resistance to Apoptosis: The Role of the Bcl-Xl Pathway
Mitchell WB. et al, (2011), BLOOD, 118, 524 - 524
Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia.
Psaila B. et al, (2011), J Thromb Haemost, 9, 2302 - 2310
Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia.
Barsam SJ. et al, (2011), Blood, 117, 5723 - 5732
Platelet Function and Response to Thrombopoietin Mimetics In Wiskott-Aldrich Syndrome/X-Linked Thrombocytopenia
Bussel JB. et al, (2010), BLOOD, 116, 613 - 614
The Effect of Eltrombopag on Human Platelet Resistance to Apoptosis: The Role of the Bcl-Xl Pathway.
Mitchell WB. et al, (2010), BLOOD, 116, 1044 - 1044
Stability of measurement of the immature platelet fraction.
Ruisi MM. et al, (2010), Am J Hematol, 85, 622 - 624
MEGAKARYOCYTES SUPPORT THE INTEGRITY OF BONE MARROW (BM) VASCULAR NICHES AND ATTRACT METASTATIC TUMOUR CELLS TO THE BM IN MURINE MODELS OF METASTASIS AND IN PATIENTS WITH CARCINOMA
Psaila B. et al, (2010), HAEMATOLOGICA, 95, 477 - 478
MEGAKARYOCYTES SUPPORT THE INTEGRITY OF BONE MARROW (BM) VASCULAR NICHES AND ATTRACT METASTATIC TUMOUR CELLS TO THE BM IN MURINE MODELS OF METASTASIS AND IN PATIENTS WITH CARCINOMA
Psaila B. et al, (2010), HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 95, 477 - 478
Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases.
Psaila B. et al, (2009), Blood, 114, 4777 - 4783
Interactions Between Megakaryocytes and Tumour Cells at the Bone Marrow Vascular Stem Cell Niche Promote Tumour Growth and Metastasis
Psaila B. et al, (2009), BLOOD, 114, 194 - 194
Megakaryocytes and the vascular niche in bone marrow metastasis
Psaila B. et al, (2009), CLINICAL & EXPERIMENTAL METASTASIS, 26, 892 - 892
The metastatic niche: adapting the foreign soil.
Psaila B. and Lyden D., (2009), Nat Rev Cancer, 9, 285 - 293
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial.
Bussel JB. et al, (2009), Lancet, 373, 641 - 648
Role of Bone Microenvironment/Metastatic Niche in Cancer Progression
Podolanczuk A. et al, (2009), BONE AND CANCER, 89 - 101
Efficacy and Safety of Repeated Intermittent Treatment with Eltrombopag in Patients with Chronic Idiopathic Thrombocytopenic Purpura
Bussel JB. et al, (2008), BLOOD, 112, 1176 - 1177
Refractory immune thrombocytopenic purpura: current strategies for investigation and management.
Psaila B. and Bussel JB., (2008), Br J Haematol, 143, 16 - 26
Fc receptors in immune thrombocytopenias: a target for immunomodulation?
Psaila B. and Bussel JB., (2008), J Clin Invest, 118, 2677 - 2681
Fc receptors in immune thrombocytopenias: a target for immunomodulation?
Psaila B. and Bussel JB., (2008), JOURNAL OF CLINICAL INVESTIGATION, 118, 2677 - 2681